UPDATE: Wedbush Lowers PT to $25 on Molina Healthcare

A report from Wedbush reiterates its Outperform rating and lowers its price target from $30 to $25 on Molina Healthcare MOH. The report states, “Our price target reflects the growth opportunity from Medicaid expansion ($40B pipeline). Risks to the attainment of our price target include high exposure to government businesses and the company's position as a price taker." MOH closed yesterday at $18.32.